US HQ of Danish parent, major insulin producer Sanofi US US operations of global pharma, produces insulin MannKind Corporation Focus on Afrezza inhaled insulin Becton, Dickinson and Company Manufactures insulin pens, syringes Embecta Corp
, L-
They were originally FDA-approved for Type 2 diabetes and insulin resistance but have since been approved for so many other things, including obesity, sleep apnea, etc., with additional benefits like reduced risk of heart disease
Conclusion Healthy eating, physical activity, and behavioural support can improve overall treatment outcomes
However, so far, no therapeutic drugs have been able to meet all these requirements, especially when it comes to improving fibrosis